(iii) Dan et al. (110) constructed CAR-Tregs to target carcinoembryonic antigen to treat colitis in mice and found that CAR-Tregs can accumulate at the inflammation site in mice and inhibit colitis development. The gene discussed is CEACAM5; the disease is colitis.